![Stephen A. Gorgol](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen A. Gorgol
Finanzdirektor/CFO bei BioVex, Inc.
Ursprung des Netzwerks ersten Grades von Stephen A. Gorgol
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
BioVex, Inc.
![]() BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
BioVex Group, Inc.
![]() BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA.
6
| Subsidiary | Biotechnology | 6 |
iVOW, Inc.
![]() iVOW, Inc. Medical/Nursing ServicesHealth Services iVOW Inc, formerly Vista Medical Technologies, Inc. (VMTI) is a disease state management company focused on the treatment of morbid obesity. The company operates two business units: Obesity Surgical and Medical Management Services and Visualization Technology. The Obesity Surgical and Medical Management Services business, operated by the Company's wholly owned subsidiary, VOW Solutions, Inc., provides services to physicians and hospitals involved in the surgical treatment of morbid obesity. Its services include management of the Company's original product offering, the Laparoscopic Bariatric Surgery Preceptorship, an introduction to starting a minimally invasive gastric bypass surgical program. In addition, the business offers consulting and program management services, which enable the efficient operation of obesity surgery programs.
3
| Extinct | Medical/Nursing Services | 3 |
Plymouth State University
3
| College/University | Other Consumer Services | 3 |
uniQure, Inc.
![]() uniQure, Inc. BiotechnologyHealth Technology Part of uniQure NV, uniQure, Inc. provides research and development services of human gene based therapies. The company is based in Lexington, MA.
1
| Subsidiary | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephen A. Gorgol
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
PEGASYSTEMS INC. | Information Technology Services | Comptroller/Controller/Auditor | |
Silicon Storage Technology, Inc.
![]() Silicon Storage Technology, Inc. SemiconductorsElectronic Technology Silicon Storage Technology, Inc. designs, manufactures and markets nonvolatile memory solutions. It supplies flash memory semiconductor devices for the digital consumer, networking, wireless communications and the Internet computing markets. The firm produces and sells semiconductor products, including flash controllers and controller-based modules, smart card integrated circuits and modules, flash microcontrollers and radio frequency devices and modules. The company was founded in 1989 and is headquartered in San Jose, CA. | Semiconductors | Director/Board Member | |
Trellis Bioscience, Inc.
![]() Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
ProterixBio, Inc.
![]() ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
Alantos Pharmaceuticals Holding, Inc.
![]() Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member | |
Achronix Semiconductor Corp.
![]() Achronix Semiconductor Corp. SemiconductorsElectronic Technology Achronix Semiconductor Corp. offers high-density and high-performance application-targeted field programmable gate arrays. Its products include Speedster22i HD, Speedster22i HP, ACE, Boards, Documentation and Video Demos. The firm also offers the Achronix CAD environment (ACE), an easy-to-use, mature, robust design-tool suite for its customers and ACE includes integrated support for industry-standard synthesis tools Synplify Pro and Precision Synthesis. The company was founded by John Lofton Holt, Rajit Manohar, Virantha N. Ekanayake, and Clinton W. Kelly VI in 2004 and is headquartered in Santa Clara, CA. | Semiconductors | Director/Board Member | |
Lightwire, Inc.
![]() Lightwire, Inc. Packaged SoftwareTechnology Services Lightwire, Inc. manufactures optical networking equipment. Its products include optical transceiver modules and ethernet optoelectronic interconnects. The company was founded by Kalpendu Shastri in 2002 and is headquartered in Allentown, PA. | Packaged Software | Director/Board Member | |
Forbion Co-Investment II Coöperatief UA
![]() Forbion Co-Investment II Coöperatief UA Investment ManagersFinance Part of Forbion Capital Partners Management Holding BV, the venture capital firm, Forbion Co-Investment II Coöperatief UA, is based in Naarden, Netherlands. Forbion Co-Investment II Coöperatief UA operates as a venture capital firm. The Dutch company was founded in 2000 by Bart Bergstein, Hugo Alexander Slootweg, Martien van Osch. | Investment Managers | Founder | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
ICAD, INC. | Medical Specialties | Director/Board Member | |
Xention Pharma Ltd.
![]() Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TherOx, Inc.
![]() TherOx, Inc. Medical SpecialtiesHealth Technology TherOx, Inc. operates as a medical device company which focuses on developing and commercializing therapies to treat ischemic and oxygen deprived tissue. Its SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge that controls cartridge operation wherein SSO2 solution is created and mixed with the patient's blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded by David B. Musket, Paul J. Zalesky and J. Richard Spears in 1994 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
BioVex Ltd.
![]() BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Bentley University | College/University | Graduate Degree | |
Formatech, Inc.
![]() Formatech, Inc. Pharmaceuticals: MajorHealth Technology Formatech, Inc. develops and manufactures therapeutic products. The firm specializes in contract research & development and aseptic contract manufacturing. It also offers liquid fills, lyophilization, compounding, and development services. The company was founded by Benjamin S. Isaacs in 1993 and is headquartered in Andover, MA. | Pharmaceuticals: Major | Chief Operating Officer | |
Indian Institute of Technology Madras
![]() Indian Institute of Technology Madras Other Consumer ServicesConsumer Services The Indian Institute of Technology, Madras, is among the foremost of institutes of national importance in higher technological education and in basic and applied research. The Institute, with nearly 360 faculty, 4000 students, 1250 administrative and supporting staff, is a self-contained campus and is located in a beautiful, wooded land of about 250 hectares in South Madras | College/University | Undergraduate Degree | |
Roche Glycart AG
![]() Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Vrije Universiteit Amsterdam | College/University | Undergraduate Degree | |
New Science Ventures LLC
![]() New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | Investment Managers | Founder | |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Founder | |
Biopure, Inc. | Corporate Officer/Principal | ||
Juventas Therapeutics, Inc.
![]() Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
Oxyrane UK Ltd.
![]() Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Resolve Therapeutics LLC
![]() Resolve Therapeutics LLC BiotechnologyHealth Technology Resolve Therapeutics LLC operates as a biotechnology company. It engages in the development of biotechnology drugs. The firm specializes in treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematous and Sjogren’s syndrome. The company was founded by James Posada in 2010 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Tigerconnect, Inc.
![]() Tigerconnect, Inc. Packaged SoftwareTechnology Services Tigerconnect, Inc. provides secure mobile messaging services. It offers secure, real-time mobile messaging for the enterprise, empowering organizations to work more securely. The company serves healthcare, enterprise, personal and developers. The company was founded by Jeffrey Albert Evans, Andrew A. Brooks and Brad Brooks in 2010 and is headquartered in Santa Monica, CA. | Packaged Software | Director/Board Member | |
UNIQURE N.V. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
REPLIMUNE GROUP, INC. | Biotechnology | Founder Director/Board Member General Counsel Investor Relations Contact | |
NorthSea Therapeutics BV
![]() NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Oxyrane, Ltd. | Chairman Director/Board Member | ||
Azafaros BV
![]() Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Impella Cardiosystems AG
![]() Impella Cardiosystems AG Medical SpecialtiesHealth Technology Impella Cardiosystems AG develops, manufactures, and markets minimally invasive cardiovascular support systems. The company is based in Aachen, Germany. The German company was founded by Thorsten Sieß. | Medical Specialties | Director/Board Member | |
Amt NV | Chairman | ||
NewAmsterdam Pharma Holding BV
![]() NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Chairman | |
VectorY BV
![]() VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistik
International
Vereinigte Staaten | 30 |
Niederlande | 10 |
Vereinigtes Königreich | 6 |
Deutschland | 4 |
Belgien | 3 |
Sektoral
Health Technology | 22 |
Technology Services | 7 |
Commercial Services | 6 |
Electronic Technology | 5 |
Finance | 5 |
Operativ
Director/Board Member | 134 |
Corporate Officer/Principal | 37 |
Undergraduate Degree | 16 |
Independent Dir/Board Member | 15 |
Director of Finance/CFO | 15 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Somu Subramaniam | 49 |
Hugo Slootweg | 34 |
Leonard Post | 25 |
Steven Prelack | 15 |
Philippe M. R. Guinot | 13 |
Pamela Esposito | 13 |
Scott R. Pancoast | 13 |
Robert J. de Vaere | 12 |
Suzette Dutch | 11 |
Philip Astley-Sparke | 11 |
Jean-Sébastien Cleiftie | 10 |
Howard Goldsweig | 9 |
John E. Kennedy | 7 |
Anne Marie Woodland | 7 |
Kevin Lafond | 6 |
- Börse
- Insiders
- Stephen A. Gorgol
- Unternehmensverbindungen